For example, the Myc/GCN2/eIF2α negative feedback loop was shown to limit protein synthesis and prevent Myc-dependent apoptosis in colorectal cancer, while the FGFR3/Myc positive feedback loop provided new opportunities for targeted therapies in bladder cancer 55, 56. This evidence concerns the gene MYC and urinary bladder carcinoma.